CRIS Current Research Information System

MURATORI, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.460
AS - Asia 5.383
EU - Europa 4.969
SA - Sud America 368
AF - Africa 362
OC - Oceania 20
Totale 18.562
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.389
CN - Cina 1.715
SG - Singapore 1.628
GB - Regno Unito 1.270
VN - Vietnam 1.032
IT - Italia 889
DE - Germania 716
SE - Svezia 615
HK - Hong Kong 378
IN - India 302
RU - Federazione Russa 272
UA - Ucraina 264
BR - Brasile 249
FR - Francia 198
IE - Irlanda 176
NL - Olanda 132
KR - Corea 112
ZA - Sudafrica 96
EE - Estonia 86
CI - Costa d'Avorio 78
FI - Finlandia 77
TG - Togo 72
CH - Svizzera 69
JP - Giappone 66
SC - Seychelles 64
AR - Argentina 55
BG - Bulgaria 42
CA - Canada 38
AT - Austria 35
JO - Giordania 32
EC - Ecuador 27
ID - Indonesia 27
PL - Polonia 24
MX - Messico 23
NG - Nigeria 22
BD - Bangladesh 21
BE - Belgio 21
TR - Turchia 15
GR - Grecia 14
RO - Romania 14
AU - Australia 12
HR - Croazia 12
ES - Italia 11
PY - Paraguay 10
MA - Marocco 9
CL - Cile 8
SA - Arabia Saudita 8
IQ - Iraq 7
IR - Iran 7
LT - Lituania 7
NZ - Nuova Zelanda 7
PT - Portogallo 7
MY - Malesia 6
TN - Tunisia 6
UY - Uruguay 5
CZ - Repubblica Ceca 4
PH - Filippine 4
PK - Pakistan 4
VE - Venezuela 4
AL - Albania 3
CO - Colombia 3
DO - Repubblica Dominicana 3
EG - Egitto 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
AO - Angola 2
AZ - Azerbaigian 2
BO - Bolivia 2
DZ - Algeria 2
FK - Isole Falkland (Malvinas) 2
IL - Israele 2
LB - Libano 2
LU - Lussemburgo 2
NO - Norvegia 2
OM - Oman 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
GA - Gabon 1
GL - Groenlandia 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
PA - Panama 1
PG - Papua Nuova Guinea 1
RS - Serbia 1
RW - Ruanda 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 18.559
Salva come PNG Salva come JPEG
Città #
Southend 1.105
Singapore 1.060
Fairfield 927
Ashburn 780
Dong Ket 564
Chandler 552
Seattle 439
Woodbridge 436
Houston 409
Santa Clara 382
Hong Kong 376
Wilmington 376
Hefei 326
Cambridge 325
Princeton 258
Ann Arbor 219
Beijing 204
Dublin 175
Boardman 171
Jacksonville 168
Bologna 130
Nanjing 128
Seoul 110
Padova 107
Westminster 105
Berlin 99
Ho Chi Minh City 99
Los Angeles 96
Hanoi 89
Jinan 82
Frankfurt am Main 80
Abidjan 78
Lomé 72
Tokyo 64
Milan 63
Helsinki 62
Bern 56
Shenyang 56
Buffalo 55
Saint Petersburg 55
Dallas 53
San Diego 48
Changsha 43
New York 42
Redondo Beach 41
Sofia 40
Hebei 39
Rome 37
Bremen 36
Mülheim 36
Des Moines 34
Guangzhou 34
Amman 32
Nanchang 32
Turin 31
Phoenix 30
Bengaluru 29
Tianjin 28
Shanghai 26
São Paulo 25
Zhengzhou 24
London 23
Brussels 21
Haikou 21
Hangzhou 21
Medford 21
Munich 21
Nuremberg 21
Vienna 21
Abeokuta 20
Dearborn 20
Taiyuan 20
Ningbo 19
Bühl 18
Mahé 18
Norwalk 18
Da Nang 17
Falkenstein 17
Jiaxing 17
Verona 17
Falls Church 16
Jakarta 16
Taizhou 16
Yubileyny 16
Chicago 15
Haiphong 15
Moscow 15
Toronto 15
San Francisco 14
Warsaw 14
Olalla 13
Orem 13
Bolzano 12
Fuzhou 12
Redwood City 12
Washington 12
Wuhan 12
Chengdu 11
Fremont 11
Lauterbourg 11
Totale 12.320
Salva come PNG Salva come JPEG
Nome #
Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence 305
Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil antibodies in coeliac disease before and after gluten free diet. 278
A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis 250
Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type. 234
Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. 228
Clinical features of type 1 autoimmune hepatitis in elderly Italian patients 223
Clinical and serological profile of primary biliary cirrhosis in men. 217
Anti-nuclear antibodies giving the “multiple nuclear dots” (MND) or the “rim-like/membranous” (RL/M) patterns: diagnostic accuracy for primary biliary cirrhosis. 207
'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? 206
Application of the 2010 American Association for the study of liver diseases criteria of remission to a cohort of Italian patients with autoimmune hepatitis. 206
Autoimmune liver disease and concomitant extrahepatic autoimmune disease 205
Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. 203
A COMPLEX IMMUNOREGULATORY DEFICIENCY CHARACTERISES TYPE 1 AUTOIMMUNE HEPATITIS. 198
Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C 197
Antinuclear antibodies in COVID 19 197
Serum antibody reactivity to human intracisternal A-type particle retrovirus proteins in systemic sclerosis patients 196
SPECIFICITY OF ANTI-SP100 ANTIBODY FOR PRIMARY BILIARY CIRRHOSIS. 193
Anti-actin IgA antibodies in severe coeliac disease 192
Multiple nuclear dots and rim-like/membranous IgG isotypes in primary biliary cirrhosis. 190
Acute icteric hepatitis induced by a short course of low-dose cyclophosphamide in a patient with lupus nephritis 188
Antimitochondrial antibodies positive autoimmune hepatitis with acute onset 180
Autoantibodies in Autoimmune Hepatitis 175
Clinical Impact and behaviour of serum autoantibodies in adult liver transplantation 169
Diagnosis and therapy of autoimmune hepatitis. 168
CLINICAL FEATURES OF PRIMARY BILIARY CIRRHOSIS IN YOUNG AND ELDERLY PATIENTS. 168
Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. 168
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 167
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 166
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 165
Autoimmune liver disease 2007. 164
PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis. 162
Features and Progression of Asymptomatic Autoimmune Hepatitis in Italy 161
COVID-19 and Immunological Dysregulation: Can Autoantibodies be Useful? 161
Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype 159
Antifilamentous Actin Antibodies by ELISA for the Diagnosis of Type 1 Autoimmune Hepatitis. 157
Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study 157
Primary biliary cirrhosis specific anti-nuclear antibodies in patients from Spain. 156
Clinical and serological profile of primary biliary cirrhosis in young and elderly patients. 156
The western immunoblotting pattern of anti-mitochondrial antibodies is independent of the clinical expression of primary biliary cirrhosis 156
Autoimmune hepatitis in Italy: the Bologna experience. 155
Antibodies to soluble liver antigen in patients with various liver diseases: A multicentre study 154
ARFI elastography in patients with chronic autoimmune liver diseases: A preliminary study 154
Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value 154
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 154
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 154
Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C. 153
Specific antinuclear reactivities in primary biliary cirrhosis 151
Anti-saccharomyces cerevisiae antibodies (ASCA) in coeliac disease. 151
Antitransglutaminase antibodies and giardiasis 149
Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study 148
Redistribution of regulatory T-cells across the evolving stages of chronic hepatitis C. 146
PML NUCLEAR BODY COMPONENT SP140 IS A NOVEL AUTOANTIGEN IN PRIMARY BILIARY CIRRHOSIS. 145
Anti-ribosomal P protein antibody: an autoreactivity devoid of prognostic value in patients with autoimmune hepatitis. 145
Evidence of a genetic basis for the different geographic occurrences of liver/kidney microsomal antibody type 1 in hepatitis C. 143
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 143
Blood-Based Non-Invasive Tests of Hepatic Fibrosis in Autoimmune Hepatitis: Application among Selected Patients Leads to Higher Accuracy 140
Immunoglobulin GM and KM allotypes and prevalence of anti-LKM1 autoantibodies in patients with hepatitis C virus infection. 140
The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. 139
Diagnostic approach to autoimmune hepatitis 139
Autoimmune liver disease serology in acute hepatitis E virus infection 137
Standardization of Autoantibody Testing in Autoimmune Hepatitis 135
Celiac disease in autoimmune cholestatic liver disorders 135
Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis. 133
Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis. 132
INCREASED REGULATORY POTENTIAL AND IMBALANCE OF THE VDELTA1/VDELTA2 RATIO IN PATIENTS WITH DIFFERENT MANIFESTATIONS OF HEPATITIS C. 132
HCV and autoimmunity. 131
De novo autoimmune hepatitis in liver transplant: State-of-the-art review 131
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. 129
Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases. 129
DETECTION OF MND AND RL/M ANTI-NUCLEAR ANTIBODIES PATTERNS: A RELIABLE DIAGNOSTIC TOOL IN ANTI-MITOCHONDRIAL ANTIBODIES NEGATIVE PRIMARY BILIARY CIRRHOSIS. 129
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. 128
Two of them do it better: Novel serum biomarkers improve autoimmune hepatitis diagnosis 127
Regulatory T cell defects in adult autoimmune hepatitis. 126
Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirin 126
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System 126
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 126
Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis. 125
Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51 125
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 123
Diagnosis of primary biliary cholangitis in a "teen" male patient 123
Nuclear Envelope Protein Autoantibodies/Antilamin Autoantibodies (Chapter 26) 123
Autoantibodies in antimithocondrial antibodies negative primary biliary cholangitis. 122
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 121
Acute liver injury and anorexia nervosa: A case report 119
Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment 119
Serum Smooth Muscle Antibodies (SMA). 117
Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis 116
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 115
Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitis. 115
Hepatitis C and autoreactivity. 110
Decompensated cirrhosis as presentation of LKM1/LC1 positive type 2 autoimmune hepatitis in adulthood. A rare clinical entity of difficult management 109
Identification of new autoantigens by protein array indicates a role for IL4 neutralization in Autoimmune Hepatitis. 109
Genetic distinction between autoimmune hepatitis in Italy and North America 107
Review article: autoimmune hepatitis - current management and challenges 106
Primary Biliary Cholangitis: advances in management and treatment of the disease. 105
Anti-neutrophil cytoplasm antibodies (ANCA) in autoimmune diseases: A matter of laboratory technique and clinical setting 105
Sex differences associated with primary biliary cirrhosis. 104
Non organ specific autoantibodies in children with chronic hepatitis C virus infection 103
The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies 101
Current topics in autoimmune hepatitis. 101
Totale 15.320
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.841
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.841
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.465 0 0 0 0 0 84 44 169 132 124 90 822
2021/20222.463 189 59 175 208 204 119 76 161 102 163 581 426
2022/20232.403 333 331 127 309 130 175 96 127 376 95 184 120
2023/2024736 48 111 51 68 53 115 39 66 21 43 62 59
2024/20253.123 171 449 323 250 545 170 184 88 64 183 111 585
2025/20263.528 534 696 616 560 793 329 0 0 0 0 0 0
Totale 18.861